In light of Vyleesi being approved by the FDA for Hypoactive Sexual Desire Disorder (HSDD) in pre-menopausal women its time to revisit the science behind PT-141 (Bremelanotide). This peptide is the only legitimate aphrodisiac that activates libido and arousal in women. It also works in men in higher doses than those used in women. We will discuss all aspects of use of this peptide and any unwanted effects.
Dr. Yurth on Flow Research Collective Radio – Peptides: The Future of Anti-Aging and Regenerative Medicine
Dr. Yurth sat down with Flow Research Collective to discuss new anti-aging techniques with Peptides. Listen & watch the clips here!